Alison D. Findlay

1.1k total citations
27 papers, 765 citations indexed

About

Alison D. Findlay is a scholar working on Molecular Biology, Organic Chemistry and Biotechnology. According to data from OpenAlex, Alison D. Findlay has authored 27 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Organic Chemistry and 9 papers in Biotechnology. Recurrent topics in Alison D. Findlay's work include Microbial metabolism and enzyme function (9 papers), Synthetic Organic Chemistry Methods (9 papers) and Marine Sponges and Natural Products (9 papers). Alison D. Findlay is often cited by papers focused on Microbial metabolism and enzyme function (9 papers), Synthetic Organic Chemistry Methods (9 papers) and Marine Sponges and Natural Products (9 papers). Alison D. Findlay collaborates with scholars based in Australia, United Kingdom and United States. Alison D. Findlay's co-authors include Ian Paterson, Martin G. Banwell, Alex C. Bissember, Rajeev S. Menon, Wolfgang Jarolimek, Mandar Deodhar, Jonathan S. Foot, Gordon J. Florence, Christian Noti and Craig I. Turner and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Chemical Communications.

In The Last Decade

Alison D. Findlay

27 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison D. Findlay Australia 16 364 286 100 89 60 27 765
Roselyne Castonguay United States 15 87 0.2× 611 2.1× 115 1.1× 44 0.5× 54 0.9× 25 906
Jidong Zhu China 14 198 0.5× 752 2.6× 40 0.4× 31 0.3× 42 0.7× 34 1.1k
Andrew McGown United Kingdom 11 107 0.3× 325 1.1× 56 0.6× 57 0.6× 41 0.7× 28 661
Christian Potter United Kingdom 7 177 0.5× 587 2.1× 56 0.6× 18 0.2× 41 0.7× 9 790
Wolfgang Schwede Germany 13 158 0.4× 204 0.7× 64 0.6× 20 0.2× 60 1.0× 34 584
Yuichi Koga Japan 12 259 0.7× 386 1.3× 69 0.7× 15 0.2× 26 0.4× 22 807
Hisao Fukumoto Japan 17 119 0.3× 587 2.1× 48 0.5× 62 0.7× 58 1.0× 30 1.0k
Chie‐Hong Wang Taiwan 14 202 0.6× 355 1.2× 34 0.3× 24 0.3× 23 0.4× 26 792
Bernd Buchmann Germany 9 102 0.3× 272 1.0× 60 0.6× 20 0.2× 69 1.1× 19 510
Marta Soler Spain 15 136 0.4× 262 0.9× 132 1.3× 13 0.1× 14 0.2× 24 615

Countries citing papers authored by Alison D. Findlay

Since Specialization
Citations

This map shows the geographic impact of Alison D. Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison D. Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison D. Findlay more than expected).

Fields of papers citing papers by Alison D. Findlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison D. Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison D. Findlay. The network helps show where Alison D. Findlay may publish in the future.

Co-authorship network of co-authors of Alison D. Findlay

This figure shows the co-authorship network connecting the top 25 collaborators of Alison D. Findlay. A scholar is included among the top collaborators of Alison D. Findlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison D. Findlay. Alison D. Findlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perryman, Lara, Alison D. Findlay, Brett Charlton, et al.. (2025). The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement. Scientific Reports. 15(1). 22653–22653. 1 indexed citations
2.
Foot, Jonathan S., Alberto Buson, Mandar Deodhar, et al.. (2022). Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease. Bioorganic & Medicinal Chemistry Letters. 74. 128942–128942. 4 indexed citations
3.
Chaudhari, Nutan, Alison D. Findlay, Andrew Stevenson, et al.. (2022). Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis. Nature Communications. 13(1). 5555–5555. 22 indexed citations
4.
Findlay, Alison D., et al.. (2022). Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis. International Journal of Molecular Sciences. 23(10). 5533–5533. 25 indexed citations
5.
Leiva, Orly, Shinobu Matsuura, Vipul C. Chitalia, et al.. (2019). Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice. International Journal of Hematology. 110(6). 699–708. 30 indexed citations
6.
Saxena, D.M., et al.. (2018). Multiple Functions of Lysyl Oxidase Like-2 in Oral Fibroproliferative Processes. Journal of Dental Research. 97(11). 1277–1284. 8 indexed citations
7.
Nugent, Jeremy, Jas S. Ward, Brett D. Schwartz, et al.. (2018). Synthetic Studies on the Natural Product Myrsinoic Acid F Reveal Biologically Active Analogues. Organic Letters. 20(13). 3984–3987. 3 indexed citations
8.
Schilter, Heidi, Alison D. Findlay, Lara Perryman, et al.. (2018). The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis. Journal of Cellular and Molecular Medicine. 23(3). 1759–1770. 83 indexed citations
9.
Schilter, Heidi, Carmen Z. Cantemir-Stone, Vladimı́r Leksa, et al.. (2015). The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts. Immunology Letters. 165(2). 90–101. 15 indexed citations
10.
Foot, Jonathan S., Tin T. Yow, Heidi Schilter, et al.. (2013). PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo. Journal of Pharmacology and Experimental Therapeutics. 347(2). 365–374. 45 indexed citations
11.
Findlay, Alison D., et al.. (2009). The Enantiocontrolled Synthesis of a Highly Functionalized Cyclohexenone Related to the A-Ring of the Furanosteroid Viridin. Australian Journal of Chemistry. 62(9). 1173–1180. 6 indexed citations
12.
Paterson, Ian & Alison D. Findlay. (2009). Recent Advances in the Total Synthesis of Polyketide Natural Products as Promising Anticancer Agents. Australian Journal of Chemistry. 62(7). 624–638. 18 indexed citations
13.
Paterson, Ian, Alison D. Findlay, & Christian Noti. (2009). Total Synthesis of (−)‐Spirangien A, an Antimitotic Polyketide Isolated from the Myxobacterium Sorangium Cellulosum. Chemistry - An Asian Journal. 4(4). 594–611. 31 indexed citations
14.
Menon, Rajeev S., Alison D. Findlay, Alex C. Bissember, & Martin G. Banwell. (2009). The Au(I)-Catalyzed Intramolecular Hydroarylation of Terminal Alkynes Under Mild Conditions: Application to the Synthesis of 2H-Chromenes, Coumarins, Benzofurans, and Dihydroquinolines. The Journal of Organic Chemistry. 74(22). 8901–8903. 148 indexed citations
15.
Paterson, Ian, Alison D. Findlay, & Christian Noti. (2008). Total synthesis of (−)-spirangien A and its methyl ester. Chemical Communications. 6408–6408. 23 indexed citations
16.
Paterson, Ian, et al.. (2008). Total synthesis of pteridic acids A and B. Tetrahedron. 64(21). 4768–4777. 10 indexed citations
17.
Paterson, Ian, Alison D. Findlay, & Edward A. Anderson. (2007). Synthesis of an Advanced C10–C32 Spiroacetal Fragment and Assignment of the Absolute Configuration of Spirangien A. Angewandte Chemie International Edition. 46(35). 6699–6702. 28 indexed citations
18.
Paterson, Ian, Alison D. Findlay, & Gordon J. Florence. (2007). Total synthesis and stereochemical reassignment of (+)-dolastatin 19, a cytotoxic marine macrolide isolated from Dolabella auricularia. Tetrahedron. 63(26). 5806–5819. 23 indexed citations
19.
Paterson, Ian, Alison D. Findlay, & Gordon J. Florence. (2006). Total Synthesis and Stereochemical Reassignment of (+)-Dolastatin 19. Organic Letters. 8(10). 2131–2134. 35 indexed citations
20.
Birch, John, et al.. (2003). Engineering mRNA Translation Initiation to Enhance Transient Gene Expression in Chinese Hamster Ovary Cells. Biotechnology Progress. 19(1). 121–129. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roselyne Castonguay Breakdown of academic impact, for papers by Jidong Zhu Breakdown of academic impact, for papers by Andrew McGown Breakdown of academic impact, for papers by Christian Potter Breakdown of academic impact, for papers by Wolfgang Schwede Breakdown of academic impact, for papers by Yuichi Koga Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Chie‐Hong Wang Breakdown of academic impact, for papers by Bernd Buchmann Breakdown of academic impact, for papers by Marta Soler
Rankless by CCL
2026